Loading…
Molecular Partners AG is projected to rise to $4.37 by 2027, a +9% move from its current price of $4.02. MOLN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $3.92 | $4.03 | $4.13 | +0.05% |
| Jul 14 | $3.88 | $4.03 | $4.18 | +0.09% |
| Jul 15 | $3.86 | $4.03 | $4.21 | +0.14% |
| Jul 16 | $3.83 | $4.03 | $4.24 | +0.19% |
| Jul 17 | $3.81 | $4.03 | $4.27 | +0.24% |
| Jul 18 | $3.79 | $4.04 | $4.30 | +0.28% |
| Jul 19 | $3.77 | $4.04 | $4.32 | +0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.77 | $4.04 | $4.32 | +0.33% |
| Week 2 | $3.68 | $4.05 | $4.46 | +0.66% |
| Week 3 | $3.61 | $4.06 | $4.57 | +1.00% |
| Week 4 | $3.56 | $4.08 | $4.67 | +1.33% |
| Week 5 | $3.52 | $4.09 | $4.76 | +1.66% |
| Week 6 | $3.48 | $4.10 | $4.84 | +2.00% |
| Week 7 | $3.44 | $4.12 | $4.92 | +2.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Molecular Partners AG is a clinical-stage biotechnology company in Switzerland that designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in Phase 1 clinical trial to treat SCLC and neuroendocrine tumors. It also researches Switch-DARPin T cell engager to treat CD3 x costim x; and MP0726, a Radio-DARPin Therapy to treat ovarian cancer and other MSLNexpressing cancers.
In addition, the company develops MP0621, a Switch-DARPin candidate targeting CD16a, c-KIT, and CD47 as conditioning for hematopoietic stem cell transplantation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
Molecular Partners AG (MOLN) trades with a current price of $4.02 and has a market capitalization of $150.94M, ranking it 3988th by market cap globally. The stock sits in the Healthcare sector and is characterized by a clinical-stage biotech profile with a diverse DARPin-based pipeline. The latest price context places it near short- and mid-term moving averages, with a long-run forecast showing meaningful upside potential in the coming years.
A major floor 13.3% below — a decisive break under it would weaken the trend.
The nearest floor, 7.8% below — buyers have tended to step in here.
The nearest ceiling, 4.4% above — a clean break opens room to run.
A major ceiling 24.4% above — clearing it would confirm fresh momentum.
Key MOLN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MOLN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.05 | Sell | $4.03 | Sell |
| MA 10 | $3.98 | Buy | $3.99 | Buy |
| MA 20 | $3.93 | Buy | $3.97 | Buy |
| MA 50 | $3.99 | Buy | $4.02 | Buy |
| MA 100 | $4.25 | Sell | $4.11 | Sell |
| MA 200 | $4.18 | Sell | $4.17 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.53 | Neutral |
| Stoch RSI (14) | 72.21 | Neutral |
| CCI (20) | 72.79 | Neutral |
| Williams %R (14) | -22.76 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 5.62 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 77.24 | Neutral |
| TRIX (15) | -0.03 | Sell |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 67.67 | Neutral |
| Momentum (10) | 0.09 | Buy |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 4.09 | Sell |
| ADX (14) | 7.44 | Neutral |
| ATR (14) | 0.09 | Info |
Technically, the sentiment is BULLISH with an RSI of 50. The 50-day simple moving average is $3.99 and the 200-day simple moving average is $4.18, giving a nuanced view of near-term momentum. The stock finds support at $3.71 and faces resistance at $4.20, framing a manageable near-term trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.71 | $4.02 | $5.53 | 0% | Neutral | |
| $3.50 | $4.37 | $5.76 | +9% | Neutral | |
| $3.51 | $4.50 | $6.14 | +12% | Neutral | |
| $3.51 | $4.59 | $6.44 | +14% | Neutral | |
| $3.74 | $5.00 | $7.17 | +24% | Bullish | |
| $4.25 | $5.76 | $8.44 | +43% | Bullish | |
| $4.61 | $6.36 | $9.48 | +58% | Bullish | |
| $4.89 | $6.84 | $10.38 | +70% | Bullish | |
| $4.84 | $6.87 | $10.57 | +71% | Bullish | |
| $4.84 | $6.97 | $10.87 | +73% | Bullish | |
| $6.36 | $9.74 | $16.13 | +142% | Bullish | |
| $10.48 | $17.83 | $32.17 | +343% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.71 | $4.02 | $4.77 | +0.00% |
| August 2026 | $3.51 | $4.14 | $5.00 | +2.79% |
| September 2026 | $3.54 | $4.20 | $5.13 | +1.56% |
| October 2026 | $3.50 | $4.17 | $5.14 | -0.73% |
| November 2026 | $3.56 | $4.27 | $5.30 | +2.42% |
| December 2026 | $3.68 | $4.43 | $5.53 | +3.70% |
Click any year to see its month-by-month MOLN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MOLN price prediction for 2026 points to an average of $4.02 (low $3.71, high $5.53) — a potential gain of 0% on today's $4.02. A consolidation phase looks the most probable path here.
In 2027, MOLN is projected to trade between $3.50 and $5.76, averaging $4.37 — a potential gain of +9% from today's $4.02. That is up +9% on the projected 2026 average. Price action looks broadly range-bound.
Molecular Partners AG's 2028 outlook centres on $4.50, within a $3.51 to $6.14 range. That is up +3% on the projected 2027 average. That marks a +12% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, MOLN could reach as high as $6.44, with a base case around $4.59 and support toward $3.51 — roughly +14% from $4.02. Price action looks broadly range-bound.
Expect MOLN to range from $3.74 to $7.17 through 2030. The $5.00 average target implies a +24% move from current prices. That is up +9% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The MOLN price prediction for 2031 points to an average of $5.76 (low $4.25, high $8.44) — a potential gain of +43% on today's $4.02. Momentum favours further upside here.
In 2032, MOLN is projected to trade between $4.61 and $9.48, averaging $6.36 — a potential gain of +58% from today's $4.02. That is up +10% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Molecular Partners AG's 2033 outlook centres on $6.84, within a $4.89 to $10.38 range. That is up +8% on the projected 2032 average. That marks a +70% change versus current levels. Momentum favours further upside here.
By 2034, MOLN could reach as high as $10.57, with a base case around $6.87 and support toward $4.84 — roughly +71% from $4.02. Buyers look set to stay in control over this stretch.
Expect MOLN to range from $4.84 to $10.87 through 2035. The $6.97 average target implies a +73% move from current prices. That is up +1% on the projected 2034 average. Momentum favours further upside here.
The MOLN price prediction for 2040 points to an average of $9.74 (low $6.36, high $16.13) — a potential gain of +142% on today's $4.02. Buyers look set to stay in control over this stretch.
In 2050, MOLN is projected to trade between $10.48 and $32.17, averaging $17.83 — a potential gain of +343% from today's $4.02. That is up +83% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MOLN today (≈ 248.515122 MOLN) could be worth
$4,430.42
+$3,430.42 (+343%) by 2050 · US Dollar
Based on the average projected MOLN price of $17.83 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MOLNwould be worth at today's price.
$1,000 invested in MOLN on Jul 10, 2025 (≈ 281.690145 MOLN) would be worth
$1,133.49
+$133.49 (+13.3%) today · 1.13× · US Dollar
Based on a MOLN entry price of $3.55 vs. today's $4.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.98 | $1,011.03 | +1.1% |
| 1 month ago | $3.72 | $1,081.69 | +8.2% |
| 3 months ago | $4.33 | $928.88 | -7.1% |
| 6 months ago | $4.17 | $965.89 | -3.4% |
| 1 year ago | $3.55 | $1,133.49 | +13.3% |
| All time (5.0y) ago | $19.65 | $204.78 | -79.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MOLN forecast.
Our base-case forecast reaches $8.00 around 2040.
Implied market cap at $8.00: $300.09M
The multi-year forecast shows a bullish trajectory in the later years, with the 2030 average price at $4.99 and a 24.1% ROI. Early years, such as 2026, project an average of $4.02 with neutral sentiment, while 2040 points to an average of $9.75 and a 142.3% ROI and 2050 to an average of $17.84 with a 343.3% ROI. The trajectory from 2031 onward exhibits steadily higher averages and rising ROI, with bullish sentiment across most long-horizon years.
These figures are estimates, not guarantees, and carry inherent uncertainty.
Tap a question to reveal the answer.
2030 forecased values: min $3.74, avg $4.99, max $7.17 with ROI 24.1% and sentiment BULLISH.
Short-term (2026) shows neutral sentiment with avg $4.02. The longer horizon transitions to bullish sentiment with higher avg prices and ROI, but these are estimates and not guarantees.
Yes. The forecast shows a max of $16.14 in 2040 and $32.19 in 2050, indicating that hitting $10 is within the long-term forecast.
Current price is $4.02 and market cap is $150.94M.
2050 min $10.49, avg $17.84, max $32.19 with ROI 343.3% and sentiment BULLISH.
Molecular Partners AG Community Discussion
0Share your Molecular Partners AG price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.